Back to Careers

Juvena Therapeutics Receives FDA Orphan Drug Designation for JUV-161 for the Treatment of Myotonic Dystrophy Type 1

Back to Careers

The Science of Longevity: Stopping Aging at the Cellular Level to Prevent Disease and Improve Quality of Life” as an invited panelist for the 2023 Biotech Showcase.

Back to Careers

Juvena’s CEO, Dr. Hanadie Yousef is recognized by FierceBiotech in their 2023 shortlist of 10 of the fiercest women in life sciences.

Back to Careers

CEO Dr. Hanadie Yousef discussed the convergence of AI, healthcare, and longevity in early November in Paris at JPM 40×40 as an invited speaker amongst a curated group of global business leaders across all sectors.

Back to Careers

CEO, Dr. Yousef presented Juvena’s approach to mining the regenerative secretomes of human pluripotent stem cells to identify and develop novel disease-modifying biologics that promote tissue regeneration and repair in order to rejuvenate lives as the 14th annual drug discovery strategic summit this year.

Back to Careers

Congratulations to Juvena Therapeutics Co-Founder and CEO Dr. Yousef for being named a “Big Think” speaker at #BioFuture2023 in recognition of the company’s accelerated growth and momentum in addressing a long-standing critical gap in drug discovery by unlocking the therapeutic potential of secreted proteins in order to develop regenerative therapeutics.

Back to Careers

Our Director of Discovery and Platform, Dr. Thach Mai and CSO Dr. Jeremy O’Connell share more about Juvena’s discovery platform and approach to identifying and developing a regenerative biologics for promoting lung epithelium re-growth for the treatment of idiopathic pulmonary fibrosis at the IPF 2023 Annual summit.

Back to Careers

Juvena is delighted to have had the opportunity to participate in the Mubadala Capital Singapore Forum. CEO Dr. Yousef was on the panel, “The New Frontier of Biotech Investing & Company Creation”

Back to Careers

Juvena’s CSO, Dr. Jeremy O’Connell, and VP Dr. Mo Tabrizi attend and present our DM1 lead program at the annual Myotonic Dystrophy Foundation Conference which we are proud to sponsor

Back to Careers

National Institute on Aging Spotlights our CEO’s scientific journey and Juvena Therapeutics mission to unlock the secrets of tissue regeneration